Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 2a, Double-Blind, Randomized Adaptive Design, Placebo-Controlled, Parallel Group Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Biomarkers with Oral Colon Delivery
Sponsored by Palatin Technologies
Active
$2.6K Funding
4 People
External
Related Topics
clinical trial,
pharmacokinetics,
drug delivery,
safety assessment,
biomarkers
People
Sasha Taleban
Principal Investigator (PI)
Medicine
﹒Associate Professor
Kirsten Anderson
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator IV
Maggie Drury
(CD)
Dept of Emergency Medicine
﹒Clinical Research Coordinator I
Maria Gordon
(CD)
Az Health Sciences Division
﹒Clinical Research Manager II
